OA - Nursing Case Study

Pathophysiology

• Primary mechanism: Cartilage degradation - Osteoarthritis (OA) begins with the breakdown of articular cartilage due to mechanical stress and biochemical changes, leading to an imbalance between the synthesis and degradation of cartilage matrix, resulting in its thinning and eventual loss.

• Secondary mechanism: Subchondral bone changes - As cartilage deteriorates, increased stress is transferred to the subchondral bone, causing sclerosis, cyst formation, and osteophyte (bone spur) development, which contribute to joint pain and reduced mobility.

• Key complication: Synovial inflammation - While not as pronounced as in inflammatory arthritis, low-grade synovial inflammation in OA can exacerbate joint damage and pain, further impairing the function and quality of life of affected individuals.

Patient Profile

Demographics:

63-year-old female, retired librarian

History:

• Key past medical history: Osteoarthritis diagnosed 5 years ago, hypertension, obesity

• Current medications: Acetaminophen, Lisinopril, Ibuprofen (as needed)

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing knee pain and swelling

• Key symptoms: Stiffness in the morning, decreased range of motion, difficulty walking, occasional joint locking

• Vital signs: Blood pressure 145/92 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

During the initial assessment, the nurse noted that the patient's right knee was visibly swollen and warm to the touch compared to the left knee. The patient rated her pain as an 8 out of 10 on the pain scale, particularly exacerbated with movement, and reported that the stiffness in her knee lasted for more than an hour each morning. Her gait was noticeably altered, as she was favoring her left leg to compensate for the discomfort in her right knee. The range of motion was significantly reduced, with the patient experiencing difficulty fully extending or flexing her knee. The nurse also observed crepitus, or a crackling sensation, during passive movement of the joint.

Given the presenting symptoms and the patient's history of osteoarthritis, there is a suspicion of increased synovial inflammation or possible effusion contributing to the heightened pain and swelling. Laboratory tests were ordered, including a complete blood count (CBC) and inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), to evaluate for any signs of inflammation or infection. Additionally, an X-ray of the affected knee was requested to assess for any further joint degeneration, osteophyte formation, or other structural changes that might explain the acute exacerbation of her symptoms.

These assessment findings and diagnostic steps are crucial for determining the next course of action. The healthcare team will need to consider potential modifications to the patient's treatment plan, such as adjusting her pain management regimen or exploring more advanced interventions like intra-articular corticosteroid injections, should the imaging and lab results indicate significant synovial inflammation or other complications. The aim is to alleviate her symptoms and improve her mobility, thereby enhancing her quality of life and preventing further joint damage.

Section 2

After the initial assessment, the diagnostic results revealed some critical findings. The X-ray of the patient's right knee showed significant joint space narrowing and the presence of osteophytes, which are indicative of advanced osteoarthritis. Additionally, there was evidence of a moderate joint effusion, suggesting increased synovial fluid accumulation, likely due to inflammation. The laboratory tests showed an elevated C-reactive protein (CRP) level of 15 mg/L (normal <3 mg/L), reflecting active inflammation, while the erythrocyte sedimentation rate (ESR) was 28 mm/hr, also above the normal range for her age. The complete blood count (CBC) was unremarkable, with no signs of infection, which ruled out septic arthritis as a complication.

Given these findings, the healthcare team decided to modify the patient's treatment plan to address the inflammation and pain more effectively. The patient was started on a short course of oral nonsteroidal anti-inflammatory drugs (NSAIDs) to help reduce the inflammation and pain. Additionally, given the significant joint effusion and the patient's persistent high pain levels, an intra-articular corticosteroid injection was administered to the right knee. The aim was to provide rapid relief and improve mobility by reducing synovial inflammation. The patient was also referred to a physical therapist to begin a tailored exercise program that focuses on strengthening the muscles around the knee and improving range of motion, which is crucial for long-term management of her osteoarthritis.

Over the following days, the patient reported a modest improvement in her pain levels, now rating her discomfort as a 5 out of 10. The swelling in her knee began to decrease, and she noted less stiffness in the mornings, although some persisted. Her gait improved slightly, but she continued to favor her left leg. The patient's progress will be closely monitored, with follow-up appointments scheduled to reevaluate her condition and adjust the treatment plan as needed. The healthcare team remains vigilant for any new complications, such as potential adverse effects from medications or further loss of joint function, as they continue to guide her through managing her osteoarthritis effectively.

Section 3

Two weeks after the initial intervention, the patient returned for a follow-up appointment, reporting persistent knee discomfort and new symptoms of increased fatigue and mild fever. Her pain, now rated at 6 out of 10, had worsened, particularly during weight-bearing activities. During the physical examination, the healthcare provider noted increased warmth and mild erythema over the right knee, along with a palpable increase in joint effusion compared to the previous assessment. Notably, the patient exhibited a more pronounced antalgic gait, indicating that she was experiencing more significant challenges with mobility.

Given these developments, the healthcare team suspected a possible complication, such as pseudo-gout or an exacerbation of the inflammatory process. Consequently, they decided to conduct further diagnostic tests to clarify the situation. A repeat X-ray was performed, along with an ultrasound to assess synovial fluid characteristics. A joint aspiration was also carried out to obtain synovial fluid for analysis, aiming to rule out crystal-induced arthritis or infection. The synovial fluid analysis revealed elevated white blood cell counts with a predominance of neutrophils, but no crystals were observed, which reduced the likelihood of pseudo-gout. CRP levels remained elevated at 18 mg/L, and the ESR had climbed to 35 mm/hr, indicating ongoing inflammation.

With these findings, the healthcare team revised the treatment plan. The patient's NSAID dosage was adjusted, and a low-dose oral corticosteroid was introduced to better control systemic inflammation. Additionally, the physical therapy regimen was modified to include more non-weight-bearing exercises to reduce stress on the knee joint while maintaining muscle strength. The team also emphasized the importance of periodic monitoring to prevent further joint deterioration and to swiftly address any emerging complications. The patient was scheduled for another follow-up in two weeks to reassess her response to the adjusted treatment strategy.

Section 4

Two weeks later, the patient returned for her scheduled follow-up appointment. Upon initial assessment, she reported a slight decrease in knee pain, now rated at 4 out of 10, and a modest improvement in mobility. However, she continued to experience significant fatigue and intermittent mild fever. The healthcare provider noted that the erythema over the right knee had slightly diminished, but the warmth and joint effusion persisted. The patient's vital signs revealed a low-grade fever of 100.1°F, with a pulse rate of 88 beats per minute and blood pressure at 128/82 mmHg. Despite the slight improvement in knee discomfort, the patient's overall condition raised concerns about a systemic process potentially affecting her recovery.

The updated diagnostic results from the recent blood tests showed a slight reduction in CRP levels to 15 mg/L and ESR to 30 mm/hr, suggesting some response to the adjusted anti-inflammatory treatment. However, the persistence of systemic symptoms such as fatigue and fever prompted the healthcare team to consider other underlying conditions that might be affecting her. Given these findings, the team decided to conduct additional tests, including a complete blood count (CBC) and a rheumatoid factor (RF) test, to further explore the possibility of an autoimmune component or other inflammatory disorders.

The change in the patient's status necessitated a reevaluation of her treatment plan. While the current interventions seemed to be addressing the localized inflammation in her knee, the systemic symptoms indicated a need for a broader approach. The healthcare team discussed the potential for introducing a disease-modifying antirheumatic drug (DMARD) if the new diagnostic results warranted it. Meanwhile, they encouraged the patient to maintain her modified physical therapy regimen and to stay vigilant for any new symptoms, emphasizing the importance of early detection and management of complications. The patient was advised to return for a follow-up in one week to closely monitor her progress and adjust her treatment plan as necessary.

Section 5

At the one-week follow-up appointment, the patient reported mixed feelings about her current condition. While she noted a further reduction in knee pain, now down to a 3 out of 10, she expressed concern over her ongoing fatigue and a new symptom: stiffness in her hands and wrists, particularly in the morning. These symptoms lasted about an hour before subsiding. The healthcare provider conducted a thorough physical examination and noted slight swelling and tenderness in the small joints of the patient's hands, suggestive of an inflammatory process extending beyond the knee.

The results of the additional tests conducted the previous week had arrived. The CBC revealed mild anemia, with a hemoglobin level of 10.8 g/dL, and leukocytosis, with a white blood cell count of 12,000/µL. The rheumatoid factor (RF) test was positive, indicating a possible autoimmune component to her condition. These findings, coupled with her new symptoms, suggested the likelihood of rheumatoid arthritis rather than solely osteoarthritis. Given these developments, the healthcare team considered starting the patient on a DMARD, such as methotrexate, to target the underlying autoimmune process and hopefully alleviate her systemic symptoms.

The patient's change in status necessitated a careful discussion of her treatment plan. The healthcare provider explained the importance of addressing both the localized symptoms in her knee and the systemic manifestations of her condition. The patient was educated about the potential side effects of DMARDs and the need for regular monitoring of liver function and blood counts. She was encouraged to continue her physical therapy with modifications to accommodate her hand stiffness and to report any new or worsening symptoms promptly. A follow-up appointment was scheduled in two weeks to evaluate the response to the new treatment and make any necessary adjustments.